INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

STAASTAAR SURGICAL CO

CIK 0000718937

EDGAR filingsOpen in network
Disclosed transactions13
Buys / sells0 / 0
Max Insider Score21
Connections4with evidence

STAA · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
ZY
Zhou Lilian YanshengDirector
STAASTAAR SURGICAL CO
Grant or award
A—
3,091 sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 3851 · Ophthalmic Goods · Nov 4, 2026
  • ← Insider ofevidence
    Zhou Lilian YanshengDirector · Jun 22, 2026
  • ← Insider ofevidence
    Jiang WeiDirector · Jun 22, 2026
  • ← Insider ofevidence
    Foust WarrenInterim Co-CEO and Pres. & COO · Mar 16, 2026
9
ZY
Zhou Lilian YanshengDirector
STAASTAAR SURGICAL CO
Grant or award
A
—
5,572 sh
Jun 18, 2026
Jun 22, 2026
traded Jun 18, 2026
+4d
SEC FORM 4

Evidence

9
JW
Jiang WeiDirector
STAASTAAR SURGICAL CO
Grant or award
A—
6,182 sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC FORM 4

Evidence

13
JW
Jiang WeiDirector
STAASTAAR SURGICAL CO
Option exercise
M—
10.7K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC FORM 4

Evidence

9
JW
Jiang WeiDirector
STAASTAAR SURGICAL CO
Option exercise
M—
10.7K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC FORM 4

Evidence

16
FW
Foust WarrenInterim Co-CEO and Pres. & COO
STAASTAAR SURGICAL CO
Tax withholding
F$92K
3,448 sh
May 8, 2026May 12, 2026
traded May 8, 2026
+4dSEC FORM 4

Evidence

17
FW
Foust WarrenInterim Co-CEO and Pres. & COO
STAASTAAR SURGICAL CO
Option exercise
M—
8,175 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC FORM 4

Evidence

21
FW
Foust WarrenInterim Co-CEO and Pres. & COO
STAASTAAR SURGICAL CO
Option exercise
M—
19.6K sh
Mar 14, 2026Mar 16, 2026
traded Mar 14, 2026
+2dSEC FORM 4

Evidence

13
FW
Foust WarrenInterim Co-CEO and Pres. & COO
STAASTAAR SURGICAL CO
Option exercise
M—
9,775 sh
Mar 14, 2026Mar 16, 2026
traded Mar 14, 2026
+2dSEC FORM 4

Evidence

9
FW
Foust WarrenInterim Co-CEO and Pres. & COO
STAASTAAR SURGICAL CO
Option exercise
M—
8,175 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC FORM 4

Evidence

9
FW
Foust WarrenInterim Co-CEO and Pres. & COO
STAASTAAR SURGICAL CO
Grant or award
A—
45.1K sh
Mar 13, 2026Mar 16, 2026
traded Mar 13, 2026
+3dSEC FORM 4

Evidence

21
FW
Foust WarrenInterim Co-CEO and Pres. & COO
STAASTAAR SURGICAL CO
Option exercise
M—
19.6K sh
Mar 14, 2026Mar 16, 2026
traded Mar 14, 2026
+2dSEC FORM 4

Evidence

21
FW
Foust WarrenInterim Co-CEO and Pres. & COO
STAASTAAR SURGICAL CO
Option exercise
M—
9,775 sh
Mar 14, 2026Mar 16, 2026
traded Mar 14, 2026
+2dSEC FORM 4

Evidence